Narcolepsy Type 1 (NT1)
Neurology·MeSH: Narcolepsy
Prevalence
30.0 / 100K
4 drugs in development·3 companies·3 clinical trials
Drug Pipeline by Phase
Phase 3(2)
Compare drugs
Frequently asked questions
How many drugs are in development for Narcolepsy Type 1 (NT1)?
BioSniper tracks 4 drugs in development for Narcolepsy Type 1 (NT1) across 3 companies.
How many clinical trials target Narcolepsy Type 1 (NT1)?
There are 3 clinical trials targeting Narcolepsy Type 1 (NT1) tracked by BioSniper.
What is the prevalence of Narcolepsy Type 1 (NT1)?
The estimated prevalence of Narcolepsy Type 1 (NT1) is approximately 30.0 per 100,000 population.
Deep-dive into Narcolepsy Type 1 (NT1)
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis